PPARα agonists are highly significant in managing dyslipidemia and metabolic syndromes by reducing plasma triglyceride levels ( 8 , 8 ).
← all excerpts
Identification of PPREs and PPRE associated genes in the human genome: insights into related kinases and disease implications.
1
—
—